Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income grows, but more slowly than its trailing trend
Q2 FY2026 net income of $153.09M rose 198.9% year over year, behind the +268.9% change in trailing-twelve-month net income. Sequentially, it rose 90.6% from the prior quarter.
Context
- Net income amounted to 25.7% of revenue in FY2025, up 4.7 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 17 analysts of $780.29M (+256.1%) for the fiscal year ending Dec 2026, a slowdown from the +362.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $153.09M+90.6% QoQ
- Last fiscal yearDec 2025
- $219.13M+362.7% YoY
- LTMJun 2026
- $369.49M+268.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +198.9% | +140.9% | -58.0 pp |
| 1 year | +362.7% | +256.1% | -106.6 pp |
| 3-year CAGR | — | +98.2% | — |
| 5-year CAGR | +70.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 219.13M USD
- Year-over-year change
- +362.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 219.13M | +362.7% |
| FY2024 | 2024-12-31 | (83.42M) | -217.7% |
| FY2023 | 2023-12-31 | (26.26M) | +55.0% |
| FY2022 | 2022-12-31 | (58.35M) | — |
Net Income vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 net income of $369.49M is the 6th largest of the 7 companies compared; the peer median is $2.83B.
- Its year-over-year change of +268.9% is the 3rd highest of 7, against a peer median of +109.3%.
- Net income amounts to 30.7% of revenue for ALAB, versus a peer median of 28.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $7.11B | +41.0% | -17.0% | 34.3% | |
| LTM Aug 2026 | $4.14B | +111.2% | -6.2% | 29.8% | |
| LTM Jun 2026 | $3.02B | +107.3% | -8.8% | 15.8% | |
| LTM Aug 2026 | $2.64B | +2653.1% | — | 27.9% | |
| LTM Aug 2026 | $538.31M | +330.2% | — | 33.8% | |
| LTM Jun 2026 | $369.49M | +268.9% | — | 30.7% | |
| LTM Sep 2026 | $29.37M | -83.6% | — | 4.4% | |
| Peer median (excluding ALAB) | $2.83B | +109.3% | -8.8% | 28.9% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 30.24M | 10.68M | 234.59M | 160.03M |
| Change in Working Capital | (9.97M) | (9.68M) | (13.3M) | (65.96M) |
| Accounts Receivables | (6.04M) | 2.39M | (30.48M) | (44.34M) |
| Inventory | (19.36M) | (5.56M) | (19.29M) | (12.95M) |
| Accounts Payables | 2.13M | (4.26M) | 20.89M | 14.19M |
| Other Working Capital | 13.3M | (2.23M) | 15.59M | (22.87M) |
| Other Non-Cash Items | 1.38M | 10.76M | (4.35M) | (726K) |
| Operating Cash Flow | (35.9M) | (12.72M) | 136.68M | 319.31M |
| Capital Expenditures | (3.87M) | (2.76M) | (34.25M) | (37.54M) |
| Acquisitions (Net) | 0 | 0 | 0 | (28.79M) |
| Purchases of Investments | (88.71M) | (126.23M) | (930.58M) | (857.75M) |
| Sales of Investments | 2M | 111.21M | 208.67M | 683.11M |
| Other Investing Activities | 0 | 0 | (1.41M) | (500K) |
| Investing Cash Flow | (90.59M) | (17.77M) | (757.57M) | (241.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 672.2M | 9.8M |
| Common Stock Repurchased | (313K) | (210K) | (1.07M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.12M | (292K) | (15.29M) | 0 |
| Financing Cash Flow | 151.67M | (502K) | 655.84M | 9.8M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.18M | (30.99M) | 34.95M | 87.64M |
| Free Cash Flow | (39.77M) | (15.48M) | 102.43M | 281.76M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.